04492nam 22005534a 450 99620628490331620230120010521.01-4377-1969-4(CKB)1000000000798753(EBL)1429655(OCoLC)861539044(SSID)ssj0000483384(PQKBManifestationID)11300081(PQKBTitleCode)TC0000483384(PQKBWorkID)10572577(PQKB)11023042(MiAaPQ)EBC1429655(EXLCZ)99100000000079875320090115d2009 uy 0engur|n|---|||||txtccrClinical management of thyroid disease[electronic resource] /edited by Fredric E. Wondisford, Sally RadovickPhiladelphia Saunders/Elsevierc20091 online resource (435 p.)Description based upon print version of record.1-336-22990-X 1-4160-4745-X Includes bibliographical references and index.Front Cover; Clinical Management of Thyroid Disease; Copyright Page; Contributors; Contents; PART I Normal Thyroid Axis; Section A Anatomy; Chapter 1 Anatomy of theHypothalamic-Pituitary-Thyroid Axis; HYPOTHALAMUS AND PITUITARY; THYROID GLAND; References; Chapter 2 Thyroid Development; MORPHOLOGIC ASPECTS; DIFFERENTIATION OF THYROID FOLLICULAR CELLS; MOLECULAR GENETICS; CONCLUSIONS; References; Section B THYROID HORMONE; Chapter 3 Thyroid Hormone Synthesis; IODIDE UPTAKE BY THE SODIUM-IODIDESYMPORTER; IODIDE EFFLUX; THYROGLOBULIN; HYDROGEN PEROXIDE GENERATING SYSTEMDEFECTS IN THYROID HORMONE SYNTHESISReferences; Chapter 4 Thyroid Hormone Action; THYROID HORMONE METABOLISM AND TRANSPORT; THYROID HORMONE RECEPTORS; THYROID HORMONE RESPONSE ELEMENTS; NONGENOMIC EFFECTS OF THYROID HORMONES; THYROID HORMONE ANALOGUES; CONCLUSIONS; References; Chapter 5 Thyroid Hormone Metabolism; DEIODINASES: THIOREDOXINFOLD-CONTAINING PROTEINS; DEIODINASES IN ILLNESS; References; Section C THYROID AXIS; Chapter 6 Role of Thyrotropin-Releasing Hormone in Thyroid Axis Regulation; THYROTROPIN-RELEASING HORMONE: STRUCTURE AND FUNCTIONREGULATION OF THYROTROPIN-RELEASING HORMONESUMMARY; References; Chapter 7 Thyroid-Stimulating Hormone and Thyroid-StimulatingHormone Receptor; THYROTROPIN; THYROTROPIN RECEPTOR; References; Part II Pediatric Thyroid; Chapter 8 Screening for Congenital Disease; SCREENING STRATEGIES; CONFIRMATIONAL DIAGNOSIS; THYROID HORMONE REPLACEMENT THERAPY; SPECIAL CONSIDERATIONS; References; Chapter 9 PERMANENT PRIMARY CONGENITAL HYPOTHYROIDISM; PERMANENT PRIMARY CONGENITAL HYPOTHYROIDISM; CENTRAL CONGENITAL HYPOTHYROIDISM; References; Chapter 10 HypothyroidismReferencesChapter 14 Toxic Nodular Goiter:Toxic Adenoma andToxic Multinodular Goiter; TOXICADENOMA,TOXIC MULTINODULAR GOITER AND AUTONOMOUS THYROID FUNCTION; OVERVIEW OF MOLECULAR PATHOGENESIS; EPIDEMIOLOGY; CAUSE AND PATHOGENESIS; CLINICAL FEATURES; DIAGNOSIS; TREATMENT; CLINICAL COURSE AND PREVENTION; References; Chapter 15 Thyroid-StimulatingHormone-Induced Hyperfunction; PATHOPHYSIOLOGY; CLINICAL FEATURES; DIAGNOSTIC PROCEDURES; DIFFERENTIAL DIAGNOSIS; TREATMENT; References; Chapter 16 Hyperthyroidism and Trophoblastic Disease; HUMAN CHORIONIC GONADOTROPINDISORDERS RESULTING FROM INCREASED HUMAN CHORIONIC GONADOTROPIN CONCENTRATIONClinical Management of Thyroid Disease is an exciting new book edited by Fredric Wondisford, MD-developer of the revolutionary new drug, Thyrotropin-and Sally Radovick, MD, with contributions from experts in the field. It fulfills the niche of a succinct, clinical resource to help you translate research into practice. This full-color volume offers valuable information on thyroid cancer and non-cancerous lesions, the effect of drugs on thyroid function, genetic disorders, and more in an accessible, easy-to-read consistent format.Presents the expertise of authors and editorial staff compThyroid glandDiseasesTextbooksThyroid glandDiseases616.4/4Wondisford Fredric E847354Radovick Sally1011332MiAaPQMiAaPQMiAaPQBOOK996206284903316Clinical management of thyroid disease2342586UNISA